Bank of America’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-283
| Closed | -$4.66K | – | 8386 |
|
|
2023
Q4 | $4.66K | Hold |
283
| – | – | ﹤0.01% | 7020 |
|
|
2023
Q3 | $2.19K | Sell |
283
-232
| -45% | -$1.26K | ﹤0.01% | 7128 |
|
|
2023
Q2 | $2.68K | Sell |
515
-3,270
| -86% | -$16.7K | ﹤0.01% | 7101 |
|
|
2023
Q1 | $20.3K | Buy |
3,785
+1,955
| +107% | +$10.6K | ﹤0.01% | 6755 |
|
|
2022
Q4 | $6.79K | Sell |
1,830
-5,320
| -74% | -$23.5K | ﹤0.01% | 7004 |
|
|
2022
Q3 | $36K | Sell |
7,150
-1,456
| -17% | -$8.11K | ﹤0.01% | 6811 |
|
|
2022
Q2 | $50K | Sell |
8,606
-969
| -10% | -$5.47K | ﹤0.01% | 6831 |
|
|
2022
Q1 | $68K | Buy |
9,575
+5,427
| +131% | +$53.2K | ﹤0.01% | 7037 |
|
|
2021
Q4 | $54K | Sell |
4,148
-326
| -7% | -$5.39K | ﹤0.01% | 7185 |
|
|
2021
Q3 | $103K | Buy |
4,474
+3,546
| +382% | +$105K | ﹤0.01% | 6710 |
|
|
2021
Q2 | $41K | Sell |
928
-3,380
| -78% | -$188K | ﹤0.01% | 6922 |
|
|
2021
Q1 | $314K | Buy |
4,308
+4,089
| +1,867% | +$290K | ﹤0.01% | 5720 |
|
|
2020
Q4 | $9K | Sell |
219
-20,630
| -99% | -$924K | ﹤0.01% | 6749 |
|
|
2020
Q3 | $857K | Buy |
20,849
+5,629
| +37% | +$291K | ﹤0.01% | 4332 |
|
|
2020
Q2 | $914K | Buy |
15,220
+819
| +6% | +$75K | ﹤0.01% | 4193 |
|
|
2020
Q1 | $1.08M | Buy |
14,401
+1,505
| +12% | +$173K | ﹤0.01% | 3960 |
|
|
2019
Q4 | $1.77M | Sell |
12,896
-1,257
| -9% | -$153K | ﹤0.01% | 4096 |
|
|
2019
Q3 | $1.68M | Buy |
+14,153
| New | +$1.98M | ﹤0.01% | 4191 |
|
Bank of America's ORTX Position: Q1 2024 in Review
Bank of America sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 283 shares — an estimated $4.66K sold.
Bank of America first reported a position in ORTX in Q3 2019 and held it in 18 quarters. The position peaked at $1.77M in Q4 2019. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.
- Bank of America reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
- Bank of America sold 283 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $4.66K.
- Bank of America first reported a position in Orchard Therapeutics plc American Depositary Shares in Q3 2019 and held it in 18 quarters.
- Bank of America's Orchard Therapeutics plc American Depositary Shares position peaked at $1.77M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.
Based on Bank of America's 13F filing for Q1 2024, filed 15 May 2024.